TITLE

Comparison between the two-step and the three-step algorithms for the detection of toxigenic Clostridium difficile

AUTHOR(S)
Qutub, MO; AlBaz, N; Hawken, P; Anoos, A
PUB. DATE
July 2011
SOURCE
Indian Journal of Medical Microbiology;Jul2011, Vol. 29 Issue 3, p293
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Purpose: To evaluate usefulness of applying either the two-step algorithm (Ag-EIAs and CCNA) or the three-step algorithm (all three assays) for better confirmation of toxigenic Clostridium difficile. The antigen enzyme immunoassays (Ag-EIAs) can accurately identify the glutamate dehydrogenase antigen of toxigenic and nontoxigenic Clostridium difficile. Therefore, it is used in combination with a toxin-detecting assay [cell line culture neutralization assay (CCNA), or the enzyme immunoassays for toxins A and B (TOX-A/BII EIA)] to provide specific evidence of Clostridium difficileassociated diarrhoea. Materials and Methods: A total of 151 nonformed stool specimens were tested by Ag EIAs, TOX-A/BII EIA, and CCNA. All tests were performed according to the manufacturer's instructions and the results of Ag-EIAs and TOX-A/BII EIA were read using a spectrophotometer at a wavelength of 450 nm. Results: A total of 61 (40.7%), 38 (25.3%), and 52 (34.7%) specimens tested positive with Ag-EIA, TOX-A/BII EIA, and CCNA, respectively. Overall, the sensitivity, specificity, negative predictive value, and positive predictive value for Ag-EIA were 94%, 87%, 96.6%, and 80.3%, respectively. Whereas for TOX-A/BII EIA, the sensitivity, specificity, negative predictive value, and positive predictive value were 73.1%, 100%, 87.5%, and 100%, respectively. With the two-step algorithm, all 61 Ag-EIAs-positive cases required 2 days for confirmation. With the three-step algorithm, 37 (60.7%) cases were reported immediately, and the remaining 24 (39.3%) required further testing by CCNA. By applying the two-step algorithm, the workload and cost could be reduced by 28.2% compared with the three-step algorithm. Conclusions: The two-step algorithm is the most practical for accurately detecting toxigenic Clostridium difficile, but it is time consuming.
ACCESSION #
65286927

 

Related Articles

  • Evaluation of three enzyme immunoassays and a loop-mediated isothermal amplification test for the laboratory diagnosis of Clostridium difficile infection. Bruins, M.; Verbeek, E.; Wallinga, J.; Bruijnesteijn van Coppenraet, L.; Kuijper, E.; Bloembergen, P. // European Journal of Clinical Microbiology & Infectious Diseases;Nov2012, Vol. 31 Issue 11, p3035 

    The laboratory diagnosis of Clostridium difficile infection (CDI) consists of the detection of toxigenic Clostridium difficile, and/or its toxins A or B in stool preferably in a two-step algorithm. In a prospective study, we compared the performance of three toxin enzyme immunoassays...

  • Utility of Perirectal Swab Specimens for Diagnosis of Clostridium difficile Infection. Kundrapu, Sirisha; Sunkesula, Venkata C. K.; Jury, Lucy A.; Sethi, Ajay K.; Donskey, Curtis J. // Clinical Infectious Diseases;Dec2012, Vol. 55 Issue 11, p1527 

    For 139 patients tested for Clostridium difficile infection by polymerase chain reaction, the sensitivity, specificity, positive predictive value, and negative predictive value of testing perirectal swabs vs stool specimens were 95.7%, 100%, 100%, and 99.1%, respectively. For selected patients,...

  • Diagnostic Testing of Clostridium difficile. Baron, Ellen Jo // Infectious Disease Alert;Sep2008, Vol. 27 Issue 12, p136 

    The article focuses on the need for an adjustment in diagnostic testing algorithms in relation to Clostridium difficile-associated diarrhea (CDAD). Based on the College of American Pathologists proficiency testing survey results, enzyme-immunoassay (EIA) tests were easier and faster to perform...

  • Laboratory Diagnosis of Clostridium difficile Infections: There Is Light at the End of the Colon. Brecher, Stephen M.; Novak-Weekley, Susan M.; Nagy, Elisabeth // Clinical Infectious Diseases;Oct2013, Vol. 57 Issue 8, p1175 

    Single molecular or multi-step assays (glutamate dehydrogenase, toxin A/B, +/− molecular) are recommended for the diagnosis of Clostridium difficile infections in patients with clinically significant diarrhea. Rapid and accurate tests can improve resource allocations and improve patient...

  • Characterization of Rabbit Polyclonal Sera against Recombinant Shiga Toxin and its Subunits for Detection of Stx-Producing E. coli. Oloomi, Mana; Bouzari, Saeid // Iranian Journal of Allergy, Asthma & Immunology;2011, Vol. 10 Issue 1, p41 

    Shiga toxin (Stx) is the principal virulence factor of Shigatoxigenic Escherichia coli (STEC), a food-born pathogen associated disease with uncomplicated diarrhea or the hemolytic-uremic syndrome. In this study, rabbit polyclonal anti recombinant A, B subunits of Shiga toxin and holotoxin...

  • Expression of the cholera toxin B subunit (CT-B) in maize seeds and a combined mucosal treatment against cholera and traveler's diarrhea. Karaman, S.; Cunnick, J.; Wang, K. // Plant Cell Reports;Mar2012, Vol. 31 Issue 3, p527 

    The non-toxic B subunit (CT-B) of cholera toxin from Vibrio cholerae is a strong immunogen and amplifies the immune reaction to conjugated antigens. In this work, a synthetic gene encoding for CT-B was expressed under control of a γ-zein promoter in maize seeds. Levels of CT-B in maize plants...

  • Isolation and Characterization of a New Clostridium difficile Ribotype During a Prospective Study in a Hospital in Italy. Sisto, Francesca; Maraschini, Anna; Fabio, Giovanna; Serafino, Serena; Zago, Miriam; Scaltrito, Maria; Castaldi, Silvana // Current Microbiology;Feb2015, Vol. 70 Issue 2, p151 

    The article discusses the isolation and characterization of bacteria Clostridium difficile based on a prospective study done in a hospital in Milano, Italy. Topics include the identification of isolates through rapid ID 32A identification system and detection by enzyme-linked immunosorbent...

  • Evaluation of an Automated Rapid Diagnostic Test for Detection of Clostridium difficile. Tojo, Masayoshi; Nagamatsu, Maki; Hayakawa, Kayoko; Mezaki, Kazuhisa; Kirikae, Teruo; Ohmagari, Norio // PLoS ONE;Aug2014, Vol. 9 Issue 8, p1 

    The Verigene Clostridium difficile Nucleic Acid Test (Verigene CDF Test) (Nanosphere, Northbrook, IL, USA) is a new multiplex qualitative polymerase chain reaction (PCR) test used to detect C. difficile toxin genes in fecal specimens. To evaluate the performance of the new method, we tested 69...

  • A bedside test for Clostridium Difficile infection: an Emergency Department use. Preliminary results. MARSILIANI, D.; DE MARCO, G.; PETRUZZIELLO, C.; MERRA, G.; FRANCESCHI, F.; OJETTI, V. // European Review for Medical & Pharmacological Sciences;Sep2015, Vol. 19 Issue 17, p3169 

    OBJECTIVE: Clostridium Difficile (CD) infection is a severe cause of diarrhea in patients with prolonged hospitalization and/or previously treated with antibiotics. CD's A and B toxins are responsible for either diarrhea or septical status as well as other complications including toxic...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics